CRIS Current Research Information System

FARINA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.310
AS - Asia 7.521
EU - Europa 6.940
SA - Sud America 604
AF - Africa 466
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 20
Totale 25.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.210
SG - Singapore 2.489
CN - Cina 2.301
GB - Regno Unito 1.800
IT - Italia 1.170
VN - Vietnam 1.123
DE - Germania 910
SE - Svezia 807
HK - Hong Kong 620
UA - Ucraina 534
BR - Brasile 465
IN - India 407
RU - Federazione Russa 399
IE - Irlanda 330
FR - Francia 291
KR - Corea 193
ZA - Sudafrica 150
JP - Giappone 141
EE - Estonia 124
NL - Olanda 122
TG - Togo 104
CI - Costa d'Avorio 95
CH - Svizzera 94
FI - Finlandia 90
AR - Argentina 64
SC - Seychelles 55
BG - Bulgaria 54
ID - Indonesia 47
CA - Canada 43
BE - Belgio 38
MX - Messico 38
GR - Grecia 34
EC - Ecuador 30
TR - Turchia 28
AT - Austria 27
NG - Nigeria 24
PL - Polonia 23
EU - Europa 21
IR - Iran 21
BD - Bangladesh 18
ES - Italia 18
JO - Giordania 18
RO - Romania 16
MY - Malesia 15
CO - Colombia 14
IQ - Iraq 14
AU - Australia 13
LT - Lituania 13
LB - Libano 12
DK - Danimarca 9
PY - Paraguay 9
CZ - Repubblica Ceca 8
PH - Filippine 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
NO - Norvegia 7
VE - Venezuela 7
CL - Cile 6
KE - Kenya 6
PK - Pakistan 6
CR - Costa Rica 5
IL - Israele 5
LK - Sri Lanka 5
MU - Mauritius 5
NZ - Nuova Zelanda 5
PE - Perù 5
PT - Portogallo 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
EG - Egitto 4
HU - Ungheria 4
RS - Serbia 4
SA - Arabia Saudita 4
TN - Tunisia 4
AM - Armenia 3
CV - Capo Verde 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
MD - Moldavia 3
TW - Taiwan 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
KW - Kuwait 2
TT - Trinidad e Tobago 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 25.869
Salva come PNG Salva come JPEG
Città #
Singapore 1.650
Southend 1.517
Fairfield 1.344
Ashburn 1.018
Chandler 682
Woodbridge 645
Hong Kong 616
Wilmington 571
Seattle 568
Houston 526
Hefei 510
Cambridge 415
Princeton 395
Jacksonville 385
Ann Arbor 358
Beijing 310
Santa Clara 299
Ho Chi Minh City 275
Dublin 261
Boardman 250
Dong Ket 242
Bologna 226
Hanoi 194
Seoul 189
Nanjing 169
Westminster 161
Padova 153
Menlo Park 144
Tokyo 137
Los Angeles 135
Berlin 123
Turin 108
Lomé 104
Dallas 94
Abidjan 93
Milan 92
Buffalo 90
San Diego 84
Shenyang 82
Helsinki 79
Jinan 77
Saint Petersburg 73
Mülheim 68
Nanchang 60
New York 60
Bern 59
Redondo Beach 59
Changsha 53
Sofia 53
Bengaluru 48
São Paulo 48
Guangzhou 47
Dearborn 46
Des Moines 42
Hebei 42
Mahé 42
Florence 39
Frankfurt am Main 39
Shanghai 37
Verona 37
Tianjin 36
Brussels 35
London 35
Olalla 33
Phoenix 32
Rome 32
Zhengzhou 32
Chicago 29
Munich 28
Bremen 25
Jiaxing 25
Ningbo 25
Redwood City 24
Abeokuta 23
San Francisco 23
Falkenstein 22
Redmond 22
Da Nang 21
Kuban 21
Jakarta 20
Medford 20
Taizhou 20
Amman 18
Haikou 18
Norwalk 18
Nuremberg 18
Biên Hòa 17
Hangzhou 17
Lanzhou 17
Wuhan 17
Yubileyny 17
Toronto 16
Brooklyn 15
Guayaquil 15
Kunming 15
Ninh Bình 15
Taiyuan 15
Warsaw 15
Amsterdam 14
Vienna 14
Totale 17.197
Salva come PNG Salva come JPEG
Nome #
metodo e kit per la diagnosi prenatale di cardiopatie congenite 471
Highly active antiretroviral therapy in a resourse-limited setting: impact on the pregnancy outcome of HIV-infected women. 396
Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia 260
Fetal cardiac defects and third-trimester maternal serum placental growth factor 257
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 237
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. 226
Accuracy of fetal gender determination in the first trimester using three-dimensional ultrasound. 224
Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia. 221
PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester. 219
Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: A model to study the relevance of stress response in longevity 214
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 213
Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique 208
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. 202
IN GRAVIDANZE A TERMINE SOTTOPOSTE A INDUZIONE I LIVELLI DELL’mRNA DEL PLAC1 NEL SANGUE MATERNO SONO CORRELATI CON L’INTERVALLO DI TEMPO CHE INTERCORRE TRA LA PRIMA SOMMINISTRAZIONE DI GEL A BASE DI DINOPROSTONE E IL PARTO 201
Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome. 195
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. 193
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis. 193
Brainstem-vermis and brainstem-tentorium angles allow accurate categorization of fetal upward rotation of cerebellar vermis 192
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 191
Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. 187
Dynamic changes of fetal head descent at term before the onset of labor correlate with labor outcome and can be improved by ultrasound visual feedback 185
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 184
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients 180
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 177
PLAC4 and beta-HCG mRNA levels are not altered in the maternal circulation of pregnancy with trisomy 21 175
Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. 174
Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? 173
Velamentous cord insertion and atypical variable decelerations with no accelerations. 169
Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. 168
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 167
Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. 166
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. 163
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening. 163
Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. 161
Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening. 160
Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. 158
Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction 158
Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. 157
Analysis of the ultrasonographic findings predictive of vasa previa. 157
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. 156
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 155
Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestation is associated with maternal serum PAPP-A. 155
Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. 155
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation 155
The Tei index for evaluation of fetal myocardial performance in sick fetuses 154
Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis 154
Changes in Artery Diameters and Fetal Growth in Cases of Isolated Single Umbilical Artery 153
Delaire's cheilorhinoplasty: Unilateral cleft aesthetic outcome scored according to the EUROCLEFT guidelines 152
Cord insertion into the lower third of the uterus in the first trimester is associated with placental and umbilical cord abnormalities 152
Antioxidant supplementation in pregnant women with low antioxidant status. 152
Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. 151
Biophysical markers for abnormal placentation: first and/or second trimester 151
Delivery and immigration: the experience of an Italian hospital. 151
PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval. 151
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. 150
Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes. J Craniomaxillofac Surg. 150
Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. 150
Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height 149
A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes 149
Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study 149
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 147
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis 147
An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens 145
Ultrasound screening for congenital pyelectasis in term pregnancies 143
Bcl-2 as prognostic factor in head and neck squamous cell carcinoma. 142
Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery. 140
Lower maternal PLAC1 mRNA in pregnancies complicated with vaginal bleeding (threatened abortion <20 weeks) and a surviving fetus. 139
Time remaining in labor and probability of vaginal delivery as a function of the angle of progression in a low risk population with a normal first stage of labor. In-house observational study and comparison with the data in the literature 139
Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. 138
Effect of c-Met expression on survival in head and neck squamous cell carcinoma. 137
Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities 136
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. 134
Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis. 134
A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID ‐19) pandemic 134
Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound. 133
Impatto della HAART(Higly Active Antiretroviral Therapy) sull’outcome delle gravidanze di donne HIV positive in contesti a risorse limitate 132
LA CRIOCONSERVAZIONE DEI GAMETI: IMPLICAZIONI ALLA LUCE DELLA LEGGE 40/2004 132
Normal morphometry of fetal posterior fossa at midtrimester: brainstem-tentorium angle and brainstem-vermis angle. 131
Three-dimensional ultrasound is an accurate and reproducible technique for fetal crown-rump length measureme 131
Infezione da HIV e gravidanza: profilassi versus terapia antiretrovirale altamente efficace 130
Clinical outcome of 285 Medpor grafts used for craniofacial reconstruction. 130
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. 129
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate 129
Predizione ecografica dell’infezione congenita sintomatica da cytomegalovirus 128
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation 128
Levels of Circulating mRNA for the Tenascin-X (TNXB) Gene in Maternal Plasma at the Second Trimester in Pregnancies with Isolated Congenital Ventricular Septal Defects 128
Impact of HAART (Highly Active Antiretroviral Therapy) on the outcome of pregnancy in a resource-limited setting 128
Cell-free mRNA concentrations of plasminogen activator inhibitor-1 andtissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. 127
Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening 127
BASSI LIVELLI DI mRNA PER IL GENE PLAC1 NELLE GRAVIDANZE COMPLICATE DA PERDITE EMATICHE VAGINALI (MINACCIA D’ABORTO <20 SETTIMANE) MA CON SOPRAVVIVENZA FETALE 126
Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. 125
PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology 125
null 125
TGF Alpha Has Low Protein Expression in Nonsyndromic Clefts. 124
beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. 124
Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. 123
Predisposing factors for massive hemorrhage during Cesarean section in patients with placenta previa 123
Prospective evaluation of ultrasound and biochemical‐based multivariable models for the prediction of late pre‐eclampsia 123
Automated Measurement of the Angle of Progression in Labor: A Feasibility and Reliability Study 123
Abnormal circulating maternal mirna expression is associated with a low (<4%) cell-free dna fetal fraction 123
Totale 16.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 314
Totale 75.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.534 0 0 0 0 0 135 47 186 212 171 168 615
2021/20223.155 201 91 240 359 317 151 86 229 114 185 599 583
2022/20233.300 395 479 193 399 210 236 91 175 490 116 342 174
2023/2024892 94 157 81 94 78 130 45 64 24 49 29 47
2024/20253.615 155 553 318 264 512 249 219 98 73 197 139 838
2025/20265.689 923 1.221 1.014 786 1.190 555 0 0 0 0 0 0
Totale 26.403